[
  {
    "title": "Laboratory Corporation of America Holdings (NYSE:LH) Has Announced A Dividend Of $0.72",
    "published": 1713207819,
    "posting_price": 204.35171819,
    "close_price": 200.76730347,
    "percent_change": -1.75404188
  },
  {
    "title": "Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw",
    "published": 1713178800,
    "posting_price": 204.35171819,
    "close_price": 200.76730347,
    "percent_change": -1.75404188
  },
  {
    "title": "Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod",
    "published": 1712927400,
    "posting_price": 202.6335732,
    "close_price": 203.14703369,
    "percent_change": 0.25339359
  },
  {
    "title": "Myriad Genetics (MYGN) Announces Favorable Research Results",
    "published": 1712844000,
    "posting_price": 205.2996494,
    "close_price": 203.90734863,
    "percent_change": -0.67817981
  },
  {
    "title": "Labcorp Declares Quarterly Dividend",
    "published": 1712833140,
    "posting_price": 205.2996494,
    "close_price": 203.90734863,
    "percent_change": -0.67817981
  },
  {
    "title": "Laboratory Corp Announces Upcoming Cash Dividend Payout",
    "published": 1712821980,
    "posting_price": 205.2996494,
    "close_price": 203.90734863,
    "percent_change": -0.67817981
  },
  {
    "title": "Laboratory Corporation of America declares $0.72 dividend",
    "published": 1712819220,
    "posting_price": 205.2996494,
    "close_price": 203.90734863,
    "percent_change": -0.67817981
  },
  {
    "title": "Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit",
    "published": 1712746140,
    "posting_price": 205.95138634,
    "close_price": 204.56895447,
    "percent_change": -0.67124184
  },
  {
    "title": "Labcorp wins FDA emergency use nod for monkeypox test",
    "published": 1712736420,
    "posting_price": 205.95138634,
    "close_price": 204.56895447,
    "percent_change": -0.67124184
  },
  {
    "title": "Labcorp Gets Emergency Authorization from FDA for Home Kit to Detect Monkeypox",
    "published": 1712734241,
    "posting_price": 205.95138634,
    "close_price": 204.56895447,
    "percent_change": -0.67124184
  },
  {
    "title": "Vltava Fund Q1 2024 Letter To Shareholders",
    "published": 1712734200,
    "posting_price": 205.95138634,
    "close_price": 204.56895447,
    "percent_change": -0.67124184
  },
  {
    "title": "Labcorp receives FDA EUA for  Mpox PCR Test Home Collection Kit",
    "published": 1712728440,
    "posting_price": 205.95138634,
    "close_price": 204.56895447,
    "percent_change": -0.67124184
  },
  {
    "title": "How a 1% Dividend Equals 68% Yearly Gains",
    "published": 1712721660,
    "posting_price": 205.95138634,
    "close_price": 204.56895447,
    "percent_change": -0.67124184
  },
  {
    "title": "Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs",
    "published": 1712670874,
    "posting_price": 208.85445708,
    "close_price": 207.41279602,
    "percent_change": -0.69027067
  },
  {
    "title": "Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes",
    "published": 1712667780,
    "posting_price": 208.85445708,
    "close_price": 207.41279602,
    "percent_change": -0.69027067
  },
  {
    "title": "Labcorp (LH) Extends MRD Clinical Research With New Launch",
    "published": 1712583240,
    "posting_price": 208.49897005,
    "close_price": 207.48190308,
    "percent_change": -0.48780431
  },
  {
    "title": "Do You Think Laboratory Corporation of America Holdings (LH) Valuation is Not Attractive Anymore?",
    "published": 1712574598,
    "posting_price": 208.49897005,
    "close_price": 207.48190308,
    "percent_change": -0.48780431
  },
  {
    "title": "Here\u2019s Why Vltava Fund Sold Lockheed Martin Corporation (LMT)",
    "published": 1712574180,
    "posting_price": 208.49897005,
    "close_price": 207.48190308,
    "percent_change": -0.48780431
  },
  {
    "title": "Labcorp Launches Labcorp Plasma Detect Extending Leadership into Molecular Residual Disease Clinical Research",
    "published": 1712561311,
    "posting_price": 208.49897005,
    "close_price": 207.48190308,
    "percent_change": -0.48780431
  },
  {
    "title": "Laboratory Corp. of America Holdings stock underperforms Monday when compared to competitors",
    "published": 1712549940,
    "posting_price": 208.49897005,
    "close_price": 207.48190308,
    "percent_change": -0.48780431
  },
  {
    "title": "Labcorp Launches Labcorp\u00ae Plasma Detect\u2122 Extending Leadership into Molecular Residual Disease (MRD) Clinical Research",
    "published": 1712314800,
    "posting_price": 208.35087473,
    "close_price": 208.60760498,
    "percent_change": 0.12322015
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Laboratory (LH)",
    "published": 1712301660,
    "posting_price": 208.35087473,
    "close_price": 208.60760498,
    "percent_change": 0.12322015
  },
  {
    "title": "Labcorp announces launch of Labcorp Plasma Detect",
    "published": 1712297040,
    "posting_price": 208.35087473,
    "close_price": 208.60760498,
    "percent_change": 0.12322015
  },
  {
    "title": "Insider Sell: EVP, President Diagnostics & COO Mark Schroeder Sells Shares of Laboratory ...",
    "published": 1712156465,
    "posting_price": 208.93345393,
    "close_price": 209.57530212,
    "percent_change": 0.30720221
  },
  {
    "title": "Insider Sell: EVP, Chief Marketing Officer Amy Summy Sells 3,500 Shares of Laboratory Corp of ...",
    "published": 1712156456,
    "posting_price": 208.93345393,
    "close_price": 209.57530212,
    "percent_change": 0.30720221
  },
  {
    "title": "Here's Why Investors Should Retain Labcorp (LH) Stock for Now",
    "published": 1712071200,
    "posting_price": 213.42633691,
    "close_price": 209.28894043,
    "percent_change": -1.93855948
  },
  {
    "title": "Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research",
    "published": 1712055600,
    "posting_price": 213.42633691,
    "close_price": 209.28894043,
    "percent_change": -1.93855948
  },
  {
    "title": "Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript",
    "published": 1714499900,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Decoding Laboratory Corp of America Holdings (LH): A Strategic SWOT Insight",
    "published": 1714475040,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72",
    "published": 1714472434,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Final LDT rule lifts overhang on Quest and Labcorp, says Jefferies",
    "published": 1714462620,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Laboratory (LH), Amgen (AMGN)",
    "published": 1714460520,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Bristol-Myers Squibb (BMY) and Laboratory (LH)",
    "published": 1714443660,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Strong Performance and Strategic Acquisitions Justify Buy Rating for Laboratory Corporation of America Holdings",
    "published": 1714441620,
    "posting_price": 200.65867635,
    "close_price": 198.84176636,
    "percent_change": -0.90547293
  },
  {
    "title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
    "published": 1714398010,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp",
    "published": 1714389600,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "FDA brings lab tests under federal oversight in bid to improve accuracy and safety",
    "published": 1714389180,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B",
    "published": 1714388400,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "Quest Diagnostics, LabCorp climb following FDA testing oversight rule",
    "published": 1714387800,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "US FDA publishes final rule for laboratory developed tests",
    "published": 1714384528,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "Labcorp\u2019s companion diagnostic approved for use with Pfizer\u2019s hemophilia B gene therapy",
    "published": 1714372500,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay",
    "published": 1714370640,
    "posting_price": 196.50153997,
    "close_price": 201.60662842,
    "percent_change": 2.59798903
  },
  {
    "title": "Integer Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up",
    "published": 1714151220,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "3 Medical Products Stocks Set to Beat This Earnings Season",
    "published": 1714145400,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Laboratory Corporation of America Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags",
    "published": 1714127574,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Laboratory (LH), Fusion Pharmaceuticals (FUSN) and Integer Holdings (ITGR)",
    "published": 1714113060,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Weitz Conservative Allocation Fund Q1 2024 Commentary",
    "published": 1714112400,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Labcorp price target lowered by $11 at Baird, here's why",
    "published": 1714110720,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Weitz Multi Cap Equity Fund Q1 2024 Commentary",
    "published": 1714110000,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Weitz Large Cap Equity Fund Q1 2024 Commentary",
    "published": 1714109400,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Labcorp price target lowered by $21 at Barclays, here's why",
    "published": 1714109160,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Q1 2024 Laboratory Corporation of America Holdings Earnings Call",
    "published": 1714108016,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Laboratory (LH) and Bristol-Myers Squibb (BMY)",
    "published": 1714105560,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Laboratory (LH) Receives a Hold from Barclays",
    "published": 1714103340,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Analyst Ratings For Laboratory Corp",
    "published": 1714097220,
    "posting_price": 194.60563821,
    "close_price": 195.90905762,
    "percent_change": 0.66977474
  },
  {
    "title": "Labcorp to acquire Invitae\u2019s assets for $239M",
    "published": 1714065060,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript",
    "published": 1714060526,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View",
    "published": 1714054680,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Compared to Estimates, Labcorp (LH) Q1 Earnings: A Look at Key Metrics",
    "published": 1714051839,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Laboratory Corp of America Holdings (LH) Q1 Earnings: Surpasses Revenue Forecasts and Updates ...",
    "published": 1714048526,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp Announces 2024 First Quarter Results",
    "published": 1714042680,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024",
    "published": 1714042560,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp: Q1 Earnings Snapshot",
    "published": 1714028832,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp narrows FY24 adjusted EPS view to $14.45-$15.35 from $14.30-$15.40",
    "published": 1714025940,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp reports Q1 adjusted EPS $3.68, consensus $3.48",
    "published": 1714025820,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Laboratory Corporation of America beats Q1 estimates",
    "published": 1714024980,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp wins bid to purchase assets of Invitae for $239M",
    "published": 1714021740,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Intelligent Bio Solutions\u2019 Fingerprint Drug Screening Technology Poised For Massive Growth",
    "published": 1714020300,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp wins bid to acquire select Invitae assets for $239 mln",
    "published": 1714013160,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million",
    "published": 1714011945,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln",
    "published": 1714011793,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Labcorp Announces Winning Bid for Select Assets of Invitae",
    "published": 1714008420,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Invitae Enters into Agreement with Labcorp for Sale of Business",
    "published": 1714007940,
    "posting_price": 202.19908967,
    "close_price": 195.85969543,
    "percent_change": -3.13522393
  },
  {
    "title": "Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?",
    "published": 1713981360,
    "posting_price": 204.22336643,
    "close_price": 205.32929993,
    "percent_change": 0.54153132
  },
  {
    "title": "Laboratory Corporation of America Q1 2024 Earnings Preview",
    "published": 1713962940,
    "posting_price": 204.22336643,
    "close_price": 205.32929993,
    "percent_change": 0.54153132
  },
  {
    "title": "Notable earnings before Thursday's open",
    "published": 1713953820,
    "posting_price": 204.22336643,
    "close_price": 205.32929993,
    "percent_change": 0.54153132
  },
  {
    "title": "Invitae enters into agreement with Labcorp for $239M sale of business",
    "published": 1713947100,
    "posting_price": 204.22336643,
    "close_price": 205.32929993,
    "percent_change": 0.54153132
  },
  {
    "title": "Notable companies reporting before tomorrow's open",
    "published": 1713943500,
    "posting_price": 204.22336643,
    "close_price": 205.32929993,
    "percent_change": 0.54153132
  },
  {
    "title": "Madison Mid Cap Fund Q1 2024 Investment Strategy Letter",
    "published": 1713930000,
    "posting_price": 204.22336643,
    "close_price": 205.32929993,
    "percent_change": 0.54153132
  },
  {
    "title": "Exploring Analyst Estimates for Labcorp (LH) Q1 Earnings, Beyond Revenue and EPS",
    "published": 1713791770,
    "posting_price": 199.71071951,
    "close_price": 200.52043152,
    "percent_change": 0.40544244
  },
  {
    "title": "Goldman\u2019s buybacks basket: Buyback growth will be 13% in 2024",
    "published": 1713788940,
    "posting_price": 199.71071951,
    "close_price": 200.52043152,
    "percent_change": 0.40544244
  },
  {
    "title": "5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings",
    "published": 1713527160,
    "posting_price": 198.20981,
    "close_price": 198.95039368,
    "percent_change": 0.37363624
  },
  {
    "title": "Mayar Capital Q1 2024 Letter To Partners",
    "published": 1713526800,
    "posting_price": 198.20981,
    "close_price": 198.95039368,
    "percent_change": 0.37363624
  },
  {
    "title": "Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy? (Revised)",
    "published": 1713519240,
    "posting_price": 198.20981,
    "close_price": 198.95039368,
    "percent_change": 0.37363624
  },
  {
    "title": "Why Labcorp (LH) Could Beat Earnings Estimates Again",
    "published": 1713456616,
    "posting_price": 197.04462759,
    "close_price": 196.94587708,
    "percent_change": -0.05011581
  },
  {
    "title": "Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy?",
    "published": 1713448918,
    "posting_price": 197.04462759,
    "close_price": 196.94587708,
    "percent_change": -0.05011581
  },
  {
    "title": "Interesting LH Put And Call Options For June 21st",
    "published": 1713435600,
    "posting_price": 197.04462759,
    "close_price": 196.94587708,
    "percent_change": -0.05011581
  },
  {
    "title": "Labcorp (LH) to Report Q1 Earnings: What's in the Cards?",
    "published": 1713271320,
    "posting_price": 201.67573985,
    "close_price": 199.39472961,
    "percent_change": -1.13102857
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH)",
    "published": 1713243660,
    "posting_price": 201.67573985,
    "close_price": 199.39472961,
    "percent_change": -1.13102857
  },
  {
    "title": "Laboratory Corp. of America Holdings stock outperforms competitors despite losses on the day",
    "published": 1713240900,
    "posting_price": 201.67573985,
    "close_price": 199.39472961,
    "percent_change": -1.13102857
  }
]